Jean-Charles Soria to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Jean-Charles Soria has written about Randomized Controlled Trials as Topic.
Connection Strength
0.011
-
Pooled Analysis of the Prognostic and Predictive Effects of TP53 Comutation Status Combined With KRAS or EGFR Mutation in Early-Stage Resected Non-Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy. J Clin Oncol. 2017 Jun 20; 35(18):2018-2027.
Score: 0.011